Registry of Toxic Effects of Chemical Substances (RTECS)
Hydrazine
RTECS #
MU7175000CAS #
302-01-2Updated
December 2013Molecular Weight
32.06Molecular Formula
H4N2Synonyms
Hydrazine (ACGIH:OSHA)Hydrazine fume
Hydrazyna (Polish)
Levoxine
Nitrogen hydride
Oxytreat 35
RCRA waste number U133
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
skin /rabbit | 50%/1H | TPKVAL 4,65,1962 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
DNA adduct | /Escherichia coli | 10 µmol/L | MUREAV 89,95,1981 |
DNA Damage | liver/rat | 3 mmol/L | MUREAV 113,357,1983 |
DNA Damage | intraperitoneal/mouse | 100 mg/kg | MUREAV 415,1,1998 |
DNA Damage | oral/mouse | 100 mg/kg | MUREAV 415,1,1998 |
DNA Damage | oral/hamster | 15 mg/kg | PAACA3 24,59,1983 |
DNA Damage | lymphocyte/mammal (species unspecified) | 95 pph | BBACAQ 174,591,1969 |
DNA Damage | lung/rat | 0.5 mmol/L/20H | MUREAV 605,94,2006 |
DNA Damage | lung/human | 0.5 mmol/L/20H | MUREAV 605,94,2006 |
DNA Damage | oral/rat | 30 mg/kg | MUREAV 605,94,2006 |
DNA inhibition | oral/rat | 60 mg/kg | CRNGDP 4,953,1983 |
DNA inhibition | oral/mouse | 200 mg/kg | MUREAV 46,305,1977 |
DNA inhibition | HeLa cell/human | 50 µmol/L | CNREA8 44,59,1984 |
morphological transform | liver/human | 80 µg/L | BJCAAI 37,873,1978 |
morphological transform | other cell types/human | 35 mg/L | ITCSAF 17,719,1981 |
morphological transform | kidney/hamster | 80 µg/L | BJCAAI 37,873,1978 |
mutation in mammalian somatic cells | lymphocyte/mouse | 1 mmol/L | MUREAV 89,321,1981 |
mutation in microorganisms | /Saccharomyes cerevisiae | 200 mmol/L (-enzymatic activation step) | MUREAV 93,339,1982 |
mutation in microorganisms | /Haemophilus influenzae | 2 mmol/L (-enzymatic activation step) | MUREAV 30,9,1975 |
mutation in microorganisms | /Other microorganisms | 70 µg/L (-enzymatic activation step) | MUREAV 173,233,1986 |
mutation in microorganisms | /Salmonella typhimurium | 120 µg/plate (-enzymatic activation step) | BIZNAT 97,137,1978 |
mutation in microorganisms | /Escherichia coli | 4300 µmol/L (+enzymatic activation step) | TOLED5 31,131,1986 |
other mutation test systems | /Escherichia coli | 80 pmol/tube | MUREAV 147,79,1985 |
other mutation test systems | /Bacillus subtilis | 10 mmol/L | MUREAV 5,343,1968 |
sex chromosome loss and nondisjunction | oral/Drosophila melanogaster | 10 mmol/L | MUREAV 16,363,1972 |
Unscheduled DNA Synthesis | oral/rat | 60 mg/kg | CRNGDP 4,953,1983 |
Unscheduled DNA Synthesis | lung/rat | 250 µg/L | NTIS** AD-A075-605 |
Unscheduled DNA Synthesis | ovary/hamster | 250 µg/L | NTIS** AD-A075-605 |
Unscheduled DNA Synthesis | lung/hamster | 250 µg/L | NTIS** AD-A075-605 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | 4 mg/m3/2H (7-20D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | GISAAA 39(10),23,1974 |
inhalation/rat | 1 mg/m3/24H (1-11D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death | GISAAA 39(10),23,1974 |
inhalation/hamster | 1 ppm/6H (1Y male) | Reproductive: Paternal effects: Testes, epididymis, sperm duct | FAATDF 5,1050,1985 |
inhalation/rat | 1 mg/m3 (1-22D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | VCVN5* -,20,1989 |
intraperitoneal/mouse | 48 mg/kg (6-9D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Musculoskeletal system | NTIS** AD-A084-023 |
intraperitoneal/mouse | 80 mg/kg (6-9D pregnant) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Urogenital system | NTIS** AD-A084-023 |
intraperitoneal/rat | 100 mg/kg (6-15D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | APTOD9 19,A21,1980 |
intraperitoneal/rat | 50 mg/kg (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | APTOD9 19,A21,1980 |
intraperitoneal/rat | 30 mg/kg (7-9D pregnant) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Urogenital system | NTIS** AD-A119-706 |
intraperitoneal/rat | 30 mg/kg (7-9D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | NTIS** AD-A119-706 |
skin/rat | 50 mg/kg (9D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | NTIS** AD-A119-706 |
subcutaneous/rat | 80 mg/kg (11-20D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | AEHLAU 21,615,1970 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/hamster | lowest published toxic concentration: 1 ppm/6H/1Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Gastrointestinal: Colon tumors | FAATDF 5,1050,1985 |
inhalation/hamster | toxic concentration (other than lowest): 5 ppm/6H/1Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Olfaction: Tumors | PAACA3 21,74,1980 |
inhalation/mouse | lowest published toxic concentration: 1 ppm/6H/1Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Olfaction: Tumors | PAACA3 21,74,1980 |
inhalation/rat | lowest published toxic concentration: 5 ppm/6H/1Y- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Endocrine: Thyroid tumors | FAATDF 5,1050,1985 |
inhalation/rat | toxic concentration (other than lowest): 5 ppm/6H/1Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Olfaction: Tumors | PAACA3 21,74,1980 |
inhalation/rat | toxic concentration (other than lowest): 1 ppm/6H/1Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Olfaction: Tumors | PAACA3 21,74,1980 |
intraperitoneal/mouse | lowest published toxic dose: 400 mg/kg/5W- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Blood: Tumors Blood: Leukemia | UICMAI 7,180,1967 |
oral/mouse | lowest published toxic dose: 1951 mg/kg/2Y- continuous | Tumorigenic: Neoplastic by RTECS criteria Lung, Thorax, or Respiration: Tumors Blood: Lymphoma including Hodgkin's disease | IJCNAW 9,109,1972 |
oral/rat | lowest published toxic dose: 900 mg/kg/2Y- continuous | Tumorigenic: Neoplastic by RTECS criteria Liver: Tumors | EXPADD 33,133,1988 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/mouse | lethal concentration (50 percent kill): 252 ppm/4H | Eye: Other eye effects Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Dyspnea | AMIHAB 12,609,1955 |
inhalation/mouse | lethal concentration (50 percent kill): 1000 mg/m3/2H | VCVN5* -,20,1993 | |
inhalation/mouse | lethal concentration (50 percent kill): 320 mg/m3/4H | VCVN5* -,20,1993 | |
inhalation/mouse | lethal concentration (50 percent kill): 330 gm/m3 | Lung, Thorax, or Respiration: Acute pulmonary edema Liver: Fatty liver degeneration Liver: Other changes | TPKVAL 4,65,1962 |
inhalation/mouse | Lowest published lethal concentration: 1.5 gm/m3/2H | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Hemorrhage Blood: Changes in spleen | TPKVAL 4,65,1962 |
inhalation/mouse | lowest published toxic concentration: 0.65 gm/m3/2H | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Changes in pulmonary vascular resistance Liver: Fatty liver degeneration | TPKVAL 4,65,1962 |
inhalation/mouse | lowest published toxic concentration: 0.02 gm/m3 | TPKVAL 4,65,1962 | |
inhalation/rat | lethal concentration (50 percent kill): 750 gm/m3/4H | Brain and Coverings: Increased intracranial pressure Cardiac: Other changes Lung, Thorax, or Respiration: Changes in pulmonary vascular resistance | TPKVAL 4,65,1962 |
inhalation/rat | Lowest published lethal concentration: 0.02 gm/m3 | Kidney, Ureter, and Bladder: Other changes Blood: Hemorrhage | TPKVAL 4,65,1962 |
inhalation/rat | Lowest published lethal concentration: 1.5 gm/m3/2H | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TPKVAL 4,65,1962 |
inhalation/rat | lowest published toxic concentration: 0.65 gm/m3/2H | Behavioral: Alteration of classical conditioning | TPKVAL 4,65,1962 |
inhalation/rat | lowest published toxic concentration: 20000 mg/m3/4H | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Behavioral: Excitement Behavioral: Tetany | VCVN5* -,20,1993 |
inhalation/rat | lethal concentration (50 percent kill): 130 mg/m3/2H | VCVN5* -,20,1993 | |
inhalation/rat | lowest published toxic concentration: 23 ppm/10M | Olfaction: Deviated nasal septum | TOXID9 44,303,2005 |
inhalation/rat | lowest published toxic concentration: 16 ppm/30M | Olfaction: Deviated nasal septum | TOXID9 44,303,2005 |
inhalation/rat | lowest published toxic concentration: 13 ppm/1H | Olfaction: Deviated nasal septum | TOXID9 44,303,2005 |
inhalation/rat | lowest published toxic concentration: 3.1 ppm/4H | Olfaction: Deviated nasal septum | TOXID9 44,303,2005 |
inhalation/rat | lowest published toxic concentration: 1.6 ppm/8H | Olfaction: Deviated nasal septum | TOXID9 44,303,2005 |
inhalation/rat | Lowest published lethal concentration: 64 ppm/10M | TOXID9 44,303,2005 | |
inhalation/rat | Lowest published lethal concentration: 45 ppm/30M | TOXID9 44,303,2005 | |
inhalation/rat | Lowest published lethal concentration: 35 ppm/1H | TOXID9 44,303,2005 | |
inhalation/rat | Lowest published lethal concentration: 8.9 ppm/4H | TOXID9 44,303,2005 | |
inhalation/rat | Lowest published lethal concentration: 4.4 ppm/8H | TOXID9 44,303,2005 | |
inhalation/rat | lethal concentration (50 percent kill): 570 ppm/4H | Eye: Other eye effects Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Dyspnea | AMIHAB 12,609,1955 |
intramuscular/Dog | lethal dose (50 percent kill): 16500 µg/kg | GISAAA 16(6),53,1972 | |
intramuscular/rabbit | lethal dose (50 percent kill): 38500 µg/kg | GISAAA 16(6),53,1972 | |
intramuscular/rat | lethal dose (50 percent kill): 53500 µg/kg | GISAAA 16(6),53,1972 | |
intraperitoneal/cat | lowest published toxic dose: 20 mg/kg | Behavioral: Tetany | VCVN5* -,20,1993 |
intraperitoneal/mouse | lethal dose (50 percent kill): 62 mg/kg | MEPAAX 24,71,1973 | |
intraperitoneal/mouse | lowest published toxic dose: 100 mg/kg | Liver: Other changes Blood: Other changes Biochemical: Metabolism (intermediary): Lipids including transport | TOXID9 72,94,2003 |
intraperitoneal/rat | lethal dose (50 percent kill): 59 mg/kg | MEPAAX 24,71,1973 | |
intraperitoneal/rat | lowest published toxic dose: 20 mg/kg | Behavioral: Alteration of classical conditioning | VCVN5* -,20,1993 |
intravenous/Dog | lethal dose (50 percent kill): 25 mg/kg | MEPAAX 24,71,1973 | |
intravenous/Dog | lowest published lethal dose: 25 mg/kg | Liver: Other changes Kidney, Ureter, and Bladder: Other changes Blood: Hemorrhage | TPKVAL 4,65,1962 |
intravenous/mouse | lowest published lethal dose: 55 mg/kg | Brain and Coverings: Other degenerative changes Behavioral: Somnolence (general depressed activity) Behavioral: Convulsions or effect on seizure threshold | TPKVAL 4,65,1962 |
intravenous/mouse | lethal dose (50 percent kill): 57 mg/kg | MEPAAX 24,71,1973 | |
intravenous/rabbit | lethal dose (50 percent kill): 20 mg/kg | AMIHBC 9,199,1954 | |
intravenous/rat | lethal dose (50 percent kill): 55 mg/kg | MEPAAX 24,71,1973 | |
intravenous/rat | lowest published lethal dose: 55 mg/kg | Behavioral: Excitement Lung, Thorax, or Respiration: Acute pulmonary edema Lung, Thorax, or Respiration: Dyspnea | TPKVAL 4,65,1962 |
oral/mouse | lowest published toxic dose: 250 mg/kg | Liver: Fatty liver degeneration Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXAPA9 204,135,2005 |
oral/mouse | lowest published toxic dose: 100 mg/kg | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Other proteins | TOXID9 78,353,2004 |
oral/mouse | lowest published toxic dose: 300 mg/kg | Liver: Multiple effects Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport | TOXID9 78,353,2004 |
oral/mouse | lowest published toxic dose: 100 mg/kg | Liver: Other changes Blood: Other changes Biochemical: Metabolism (intermediary): Lipids including transport | TOXID9 72,94,2003 |
oral/mouse | lethal dose (50 percent kill): 80 mg/kg | Liver: Fatty liver degeneration Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Changes in spleen | TPKVAL 4,65,1962 |
oral/mouse | lethal dose (50 percent kill): 59 mg/kg | MEPAAX 24,71,1973 | |
oral/mouse | lethal dose (50 percent kill): 59 mg/kg | Lung, Thorax, or Respiration: Acute pulmonary edema Kidney, Ureter, and Bladder: Changes in kidney weight | VCVN5* -,20,1993 |
oral/rat | lethal dose (50 percent kill): 60 mg/kg | Lung, Thorax, or Respiration: Acute pulmonary edema Kidney, Ureter, and Bladder: Changes in kidney weight | VCVN5* -,20,1993 |
oral/rat | lowest published toxic dose: 90 mg/kg | Liver: Hepatitis (hepatocellular necrosis), diffuse Liver: Fatty liver degeneration Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXAPA9 204,135,2005 |
oral/rat | lethal dose (50 percent kill): 60 mg/kg | MEPAAX 24,71,1973 | |
oral/rat | lowest published toxic dose: 75 mg/kg | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | CRTOEC 14,975,2001 |
oral/rat | lowest published toxic dose: 90 mg/kg | Kidney, Ureter, and Bladder: Other changes in urine composition Blood: Changes in leukocyte (WBC) count Blood: Changes in other cell count (unspecified) | CRTOEC 14,975,2001 |
oral/rat | lowest published toxic dose: 120 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal Liver: Fatty liver degeneration Liver: Other changes | CRTOEC 14,975,2001 |
skin/Dog | lowest published lethal dose: 96 mg/kg | TXAPA9 21,186,1972 | |
skin/Dog | lowest published toxic dose: 3 mg/kg | Behavioral: Tetany Behavioral: Alteration of classical conditioning | VCVN5* -,20,1993 |
skin/guinea pig | lethal dose (50 percent kill): 190 mg/kg | Behavioral: Convulsions or effect on seizure threshold | XAWPA2 CWL 2-10,1958 |
skin/rabbit | lethal dose (50 percent kill): 91 mg/kg | AMIHBC 9,199,1954 | |
subcutaneous/mouse | lowest published toxic dose: 30 mg/kg | Blood: Changes in leukocyte (WBC) count Immunological Including Allergic: Increase in cellular immune response | TXCYAC 172,35,2002 |
unreported route/mouse | lethal dose (50 percent kill): 200 mg/kg | BJCAAI 6,160,1952 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/Dog | lowest published toxic concentration: 14 ppm/6H/26W- intermittent | Behavioral: Food intake (animal) Behavioral: Muscle weakness Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | AMIHBC 10,476,1954 |
inhalation/guinea pig | lowest published toxic concentration: 14 ppm/6H/14W- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | AMIHBC 10,476,1954 |
inhalation/guinea pig | lowest published toxic concentration: 5 mg/m3/24H/59D- continuous | Lung, Thorax, or Respiration: Other changes | VCVN5* -,20,1989 |
inhalation/hamster | lowest published toxic concentration: 1 ppm/6H/1Y- intermittent | Liver: Other changes Kidney, Ureter, and Bladder: Other changes Endocrine: Other changes | NTIS** AD-A086-341 |
inhalation/monkey | lowest published toxic concentration: 1 ppm/24H/90D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** AD-A086-341 |
inhalation/mouse | lowest published toxic concentration: 130 mg/m3/1H/17W- intermittent | Blood: Normocytic anemia Blood: Changes in leukocyte (WBC) count | VCVN5* -,20,1989 |
inhalation/mouse | lowest published toxic concentration: 1 ppm/24H/90D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** AD-A086-341 |
inhalation/mouse | lowest published toxic concentration: 14 ppm/6H/5W- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | AMIHBC 10,476,1954 |
inhalation/mouse | lowest published toxic concentration: 0.003 gm/m3/30D- intermittent | Lung, Thorax, or Respiration: Changes in pulmonary vascular resistance Blood: Changes in spleen Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | TPKVAL 4,65,1962 |
inhalation/rat | lowest published toxic concentration: 0.003 gm/m3/91D- intermittent | Lung, Thorax, or Respiration: Changes in pulmonary vascular resistance Blood: Changes in spleen Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | TPKVAL 4,65,1962 |
inhalation/rat | lowest published toxic concentration: 0.0005 gm/m3/30D- intermittent | Peripheral Nerve and Sensation: Recording from peripheral motor nerve | TPKVAL 4,65,1962 |
inhalation/rat | lowest published toxic concentration: 0.0005 gm/m3/213D- intermittent | Behavioral: Alteration of classical conditioning Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Hemorrhage | TPKVAL 4,65,1962 |
inhalation/rat | lowest published toxic concentration: 1 ppm/24H/90D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** AD-A086-341 |
inhalation/rat | lowest published toxic concentration: 5 ppm/6H/26W- intermittent | Behavioral: Muscle weakness Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | AMIHBC 10,476,1954 |
inhalation/rat | lowest published toxic concentration: 10 mg/m3/4H/30D- intermittent | Liver: Liver function tests impaired Kidney, Ureter, and Bladder: Other changes in urine composition Blood: Changes in bone marrow not included in above | GISAAA 40(3),29,1975 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.01 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 4,127,1974 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 71,991,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMSUDL 7,223,1987 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 71,991,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 2B | IMEMDT 71,991,1999 |
TOXICOLOGY REVIEW | AMIHBC 9,199,1954 | |
TOXICOLOGY REVIEW | ATXKA8 28,135,1971 | |
TOXICOLOGY REVIEW | MUREAV 627,10,2007 | |
TOXICOLOGY REVIEW | ENTOX* -,536,2005 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | HUTOX* -,719,1996 | |
TOXICOLOGY REVIEW | ISMEA* 10,302,2008 | |
TOXICOLOGY REVIEW | MUTAEX 25,335,2010 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 1 ppm (1.3 mg/m3) (skin) | DTLVS* 3,127,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.01 ppm (0.013 mg/m3), Carcinogen, JUL2008 | |
Occupational Exposure Limit-AUSTRIA | TRK-TMW 0.1 ppm (0.13 mg/m3);KZW 0.4 ppm (0.52 mg/m3), skin, sen, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.01 ppm (0.013 mg/m3), Skin, Carcinogen, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.01 ppm (0.013 mg/m3), skin, carc, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.1 ppm (0.13 mg/m3), short term exposure limit 0.3 ppm (0.4 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 0.1 ppm (0.1 mg/m3), FEB2006 | |
Occupational Exposure Limit-HUNGARY | ceiling concentration 0.13 mg/m3, Carcinogen, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 0.1 ppm (0.13 mg/m3), carc, skin, sen, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 0.1 ppm (0.13 mg/m3), skin, 2B carc, s1 sen, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 0.1 ppm (0.13 mg/m3), skin, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 0.1 ppm (0.1 mg/m3), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.01 ppm (0.013 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.1 ppm (0.13 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 0.01 ppm (0.013 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.05 mg/m3, MAC(short term exposure limit) 0.1 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | short term exposure limit 0.1 mg/m3, Skin, JUN2003 | |
Occupational Exposure Limit-SWEDEN | Group B Carcinogen, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.1 ppm (0.13 mg/m3), carc 2, skin, sen, JAN2011 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 1 ppm (1.3 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 1 ppm (1.3 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 0.02 ppm (0.03 mg/m3);short term exposure limit 0.1 ppm (0.13 mg/m3), carc, skin, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 1 ppm (1.3 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 1 ppm (1.3 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 1 ppm (1.3 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 1 ppm (1.3 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HYDRAZINES-air | Carcinogen ceiling concentration 0.03 ppm/120M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 38110; Number of Industries 44; Total Number of Facilities 2515; Number of Occupations 46; Total Number of Employees Exposed 60490; Total Number of Female Employees Exposed 2841 | |
National Occupational Hazard Survey 1974 | Hazard Code 38110; Number of Industries 37; Total Number of Facilities 2134; Number of Occupations 27; Total Number of Employees Exposed 11185 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division